Understanding ICH E6 (R3): Good Clinical Practice and Computerised Systems Validation

REPHINE SPEECH MARKS OPEN DIGITALISATION

In the era of digital trials, ensuring data integrity isn’t optional — it’s essential. ICH E6 (R3) redefines compliance for computerised systems — are you ready?

REPHINE SPEECH MARKS CLOSE DIGITALISATION

About this Guide

Stay ahead of GCP regulatory changes with our ICH E6 (R3) guide — designed for clinical trial sponsors, CROs, and validation experts.

The ICH E6 (R3) guideline introduces critical updates to Good Clinical Practice (GCP), focusing on computerised systems validation, data integrity, and risk-based system management. Published on January 6, 2025, and set for EMA adoption from July 23, 2025, this revision ensures clinical trials align with modern technology and regulatory compliance requirements.

Our expert guide breaks down the essential ICH E6 (R3) updates, including:

Enhanced computerised systems requirements, with a dedicated chapter on system validation, user responsibilities, and operational controls.

Risk-based computer system validation (CSV) approaches to ensure compliance while improving efficiency and data reliability.

Advanced data integrity measures, covering audit trails, user authentication, cybersecurity, and disaster recovery planning.

New system deployment guidelines, detailing approval processes, contingency planning, and user training for GCP compliance.

For a deeper dive into AIQSV, download the guide now.

Hero Image ICH E6 Guide

🔍Why download this Guide?

This guide empowers your team to:

📌 Understand key changes in computerised system validation and data integrity requirements.

📌 Ensure GCP compliance and avoid regulatory setbacks.

📌 Implement risk-based validation strategies to streamline system qualification and deployment.

📌 Prepare your organisation for evolving GCP regulations and ICH E6 (R3) standards.

Who is this guide for?

This guide is essential for professionals working with clinical trial systems and validation, including:

🔹 Clinical trial sponsors and CROs

🔹 Regulatory affairs teams

🔹 IT specialists and system validation experts

🔹 Quality and compliance professionals

Ensure your clinical trials meet the latest ICH E6 (R3) standards with expert guidance on computerised systems validation.

View our other resources and company news

GxP Consulting Readiness Banner Article

Flexible QA Support: Strengthening Pharma QA Teams

As regulatory demands grow, even strong QA teams reach their limits. Here is how flexible QA support helps pharmaceutical companies manage change, reduce risk and ...
Read More
Rephine circles banner Article

Rephine Barcelona Gains ISO/IEC 17020 Accreditation

Rephine Barcelona S.L. is now accredited to ISO/IEC 17020 as an inspection body for specific GMP and GDP audit activities. We explain what the accreditation ...
Read More
Close up of nurse holding and typing on tablet GxP Consultancy

Cross Contamination GAP Assessment: A GMP Guide

Relying on historical cleaning limits or visual cleanliness checks to justify shared manufacturing carries more regulatory risk than many sites realise. Find out what a ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Case Study

From Cosmetics to OTC: Full FDA GMP Compliance Achieved in 12 Months

A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full ...
Read More
csv blog header jan 25 Article

GDP Transport Validation: A Practical Guide for Pharmaceutical Companies

Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide ...
Read More
QMS IMP Header image case study May 25 Article

Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide

The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...
Read More
mock inspection blog header Case Study

Full GMP Internal Audit Program Executed On Time

A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

From local to global: scaling your QMS for UK–EU operations

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

Scale Your Quality System from UK to EU Without Losing Control

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards